U-Blot® Mouse CD138/SDC1 & CD3E Bispecific AntibodyCat. No. WA3952Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Mouse CD138/SDC1 & CD3E Bispecific AntibodyCat. No. WA3952
U-Blot® Mouse BCMA & CD3E Bispecific AntibodyCat. No. WA3951
U-Blot® Mouse CD19 & CD3 epsilon Antibody (1D3&145-2C11)Cat. No. WA3950
U-Blot® VACV G9&A16 complex AntibodyCat. No. WA3949
U-Blot® Human IL1RAP & CD3 Bispecific Antibody (BIF002)Cat. No. WA3948
U-Blot® Human CD41/ITGA2B & CD61/ITGB3 Antibody (PAC-1)Cat. No. WA3947
U-Blot® Human CD41/ITGA2B & CD61/ITGB3 Antibody (PAC-1)Cat. No. WA3946
U-Blot® Mouse CTLA4 & PD1 Bispecific AntibodyCat. No. WA3945
U-Blot® Mouse CTLA4 & PD1 Bispecific AntibodyCat. No. WA3944
U-Blot® Mouse CD19 & CD8 Bispecific AntibodyCat. No. WA3943
U-Blot® MGPA33 & CD3E Bispecific Antibody (MGD007)Cat. No. WA3942
U-Blot® Human CD279/PDCD1/PD1 & VEGF Bispecific Antibody (SSGJ-707)Cat. No. WA3941